NEW YORK, October 18, 2024--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a managing director and head of structured ...

On Monday, Piper Sandler maintained an Overweight rating on shares of Yeti Holdings Inc. (NYSE:NYSE:YETI), with a steady price target of $55.00. The firm expressed confidence in the company's ...

Fastly (NYSE:FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its price target on the content delivery company after it reported ...

Piper Sandler analyst Brian Mullan maintained a Hold rating on Brinker International (EAT – Research Report) today and set a price target of $97.00. The company’s shares closed last Friday at ...

Similarly, Piper Sandler downgraded ESSA’s stock to "neutral" from "overweight" and revised its price target sharply downward to $2 from $15. Piper Sandler said that the company’s valuation ...

Fintel reports that on November 8, 2024, Piper Sandler upgraded their outlook for Upstart Holdings (NasdaqGS:UPST) from Neutral to Overweight. As of October 22, 2024, the average one-year price ...

Fintel reports that on November 8, 2024, Piper Sandler downgraded their outlook for Celanese (LSE:0HUR) from Neutral to Underweight. As of October 22, 2024, the average one-year price target for ...

On Monday, Piper Sandler showed a positive outlook for shares of USCB Financial Holdings (NASDAQ: USCB), shifting its rating from Neutral to Overweight and boosting the price target to $20.00 from ...

Celanese (NYSE:CE) -4.7% in Friday's trading to its lowest in more than four years after Piper Sandler downgrades shares to Underweight from Neutral with a $98 price target, slashed from $150 ...

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a managing director and head of structured ...

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price target of $21.00. The company’s shares ...